Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha 410008, China.
Hum Gene Ther. 2011 Apr;22(4):465-75. doi: 10.1089/hum.2010.207. Epub 2011 Feb 26.
In the spinal cord, protein kinase C isoform γ (PKCγ) plays an important role in the development of central pain sensitization. However, there are currently no specific PKCγ inhibitors available. Therefore, the aim of the present study was to assess the role of PKCγ in the modulation of pain using a more selective experimental tool. Although small interfering RNAs have been used to silence genes in neurons, in vivo delivery of RNA interference (RNAi) remains a major challenge, thus limiting its applications. Here we developed a highly efficient method of lentiviral-mediated delivery of short-hairpin RNAs targeting PKCγ for in vivo gene silencing in the spinal cord of rats. This method decreased the expression of PKCγ mRNA and protein, and additionally attenuated chronic constriction injury-induced mechanical allodynia and thermal hyperalgesia for more than 6 weeks. Our study suggests that PKCγ is a potential RNAi target for neuropathic pain. Furthermore, the lentiviral vector delivery strategy holds great promise as a novel approach for the treatment of neuropathic pain and study of PKCγ gene function.
在脊髓中,蛋白激酶 C 同工型 γ(PKCγ)在中枢痛敏的发展中起着重要作用。然而,目前尚无特异性的 PKCγ 抑制剂。因此,本研究旨在使用更具选择性的实验工具来评估 PKCγ 在疼痛调节中的作用。尽管小干扰 RNA 已被用于沉默神经元中的基因,但 RNA 干扰(RNAi)的体内递送仍然是一个主要挑战,从而限制了其应用。在这里,我们开发了一种高效的方法,通过慢病毒介导的靶向 PKCγ 的短发夹 RNA 的传递,在大鼠脊髓中进行体内基因沉默。该方法降低了 PKCγ mRNA 和蛋白的表达,并在超过 6 周的时间内减轻了慢性缩窄性损伤引起的机械性痛觉过敏和热痛觉过敏。我们的研究表明,PKCγ 是治疗神经性疼痛的潜在 RNAi 靶点。此外,慢病毒载体递送策略作为治疗神经性疼痛和研究 PKCγ 基因功能的新方法具有很大的应用前景。